Industry: Service & Software
Published Date: 2025-11-16
Pages: 141 Pages
Report ld: 5453726
Request Sample
Customized Report
Pet Euthanasia Market Size(US$)

CAGR 2025-2031
7.3%
Market Size,2031
USD 314
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pet Euthanasia market is projected to grow from US$ 193 million in 2024 to US$ 314 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 463%.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pet Euthanasia market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Pet Euthanasia study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pet Euthanasia: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pet Euthanasia Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Potassium Chloride Injection
1.2.3 Oral Sleeping Pills
1.2.4 Injection of Coagulant
1.2.5 Pentobarbital Injection
1.2.6 Injection of Saturated Magnesium Sulfate
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Pet Euthanasia Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pet Hospital
1.3.3 Veterinary Clinic
1.3.4 Zoo
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pet Euthanasia Revenue Estimates and Forecasts 2020-2031
2.2 Global Pet Euthanasia Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pet Euthanasia Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pet Euthanasia Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Potassium Chloride Injection Market Size by Players
3.3.2 Oral Sleeping Pills Market Size by Players
3.3.3 Injection of Coagulant Market Size by Players
3.3.4 Pentobarbital Injection Market Size by Players
3.3.5 Injection of Saturated Magnesium Sulfate Market Size by Players
3.3.6 Others Market Size by Players
3.4 Global Pet Euthanasia Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pet Euthanasia Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pet Euthanasia Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pet Euthanasia Market Size by Type (2020-2031)
6.4 North America Pet Euthanasia Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pet Euthanasia Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pet Euthanasia Market Size by Type (2020-2031)
7.4 Europe Pet Euthanasia Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pet Euthanasia Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pet Euthanasia Market Size by Type (2020-2031)
8.4 Asia-Pacific Pet Euthanasia Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pet Euthanasia Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pet Euthanasia Market Size by Type (2020-2031)
9.4 Central and South America Pet Euthanasia Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pet Euthanasia Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pet Euthanasia Market Size by Type (2020-2031)
10.4 Middle East and Africa Pet Euthanasia Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pet Euthanasia Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Affiliate of Mars Inc.
11.1.1 Affiliate of Mars Inc. Corporation Information
11.1.2 Affiliate of Mars Inc. Business Overview
11.1.3 Affiliate of Mars Inc. Pet Euthanasia Product Features and Attributes
11.1.4 Affiliate of Mars Inc. Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.1.5 Affiliate of Mars Inc. Pet Euthanasia Revenue by Product in 2024
11.1.6 Affiliate of Mars Inc. Pet Euthanasia Revenue by Application in 2024
11.1.7 Affiliate of Mars Inc. Pet Euthanasia Revenue by Geographic Area in 2024
11.1.8 Affiliate of Mars Inc. Pet Euthanasia SWOT Analysis
11.1.9 Affiliate of Mars Inc. Recent Developments
11.2 Ruipeng Pet
11.2.1 Ruipeng Pet Corporation Information
11.2.2 Ruipeng Pet Business Overview
11.2.3 Ruipeng Pet Pet Euthanasia Product Features and Attributes
11.2.4 Ruipeng Pet Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.2.5 Ruipeng Pet Pet Euthanasia Revenue by Product in 2024
11.2.6 Ruipeng Pet Pet Euthanasia Revenue by Application in 2024
11.2.7 Ruipeng Pet Pet Euthanasia Revenue by Geographic Area in 2024
11.2.8 Ruipeng Pet Pet Euthanasia SWOT Analysis
11.2.9 Ruipeng Pet Recent Developments
11.3 The Pet Hospitals
11.3.1 The Pet Hospitals Corporation Information
11.3.2 The Pet Hospitals Business Overview
11.3.3 The Pet Hospitals Pet Euthanasia Product Features and Attributes
11.3.4 The Pet Hospitals Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.3.5 The Pet Hospitals Pet Euthanasia Revenue by Product in 2024
11.3.6 The Pet Hospitals Pet Euthanasia Revenue by Application in 2024
11.3.7 The Pet Hospitals Pet Euthanasia Revenue by Geographic Area in 2024
11.3.8 The Pet Hospitals Pet Euthanasia SWOT Analysis
11.3.9 The Pet Hospitals Recent Developments
11.4 Pet Hospital of Madison
11.4.1 Pet Hospital of Madison Corporation Information
11.4.2 Pet Hospital of Madison Business Overview
11.4.3 Pet Hospital of Madison Pet Euthanasia Product Features and Attributes
11.4.4 Pet Hospital of Madison Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.4.5 Pet Hospital of Madison Pet Euthanasia Revenue by Product in 2024
11.4.6 Pet Hospital of Madison Pet Euthanasia Revenue by Application in 2024
11.4.7 Pet Hospital of Madison Pet Euthanasia Revenue by Geographic Area in 2024
11.4.8 Pet Hospital of Madison Pet Euthanasia SWOT Analysis
11.4.9 Pet Hospital of Madison Recent Developments
11.5 BluePearl Pet Hospital
11.5.1 BluePearl Pet Hospital Corporation Information
11.5.2 BluePearl Pet Hospital Business Overview
11.5.3 BluePearl Pet Hospital Pet Euthanasia Product Features and Attributes
11.5.4 BluePearl Pet Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.5.5 BluePearl Pet Hospital Pet Euthanasia Revenue by Product in 2024
11.5.6 BluePearl Pet Hospital Pet Euthanasia Revenue by Application in 2024
11.5.7 BluePearl Pet Hospital Pet Euthanasia Revenue by Geographic Area in 2024
11.5.8 BluePearl Pet Hospital Pet Euthanasia SWOT Analysis
11.5.9 BluePearl Pet Hospital Recent Developments
11.6 RingPai Pet Hospital
11.6.1 RingPai Pet Hospital Corporation Information
11.6.2 RingPai Pet Hospital Business Overview
11.6.3 RingPai Pet Hospital Pet Euthanasia Product Features and Attributes
11.6.4 RingPai Pet Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.6.5 RingPai Pet Hospital Recent Developments
11.7 Beijing Chong'ai International Animal Hospital
11.7.1 Beijing Chong'ai International Animal Hospital Corporation Information
11.7.2 Beijing Chong'ai International Animal Hospital Business Overview
11.7.3 Beijing Chong'ai International Animal Hospital Pet Euthanasia Product Features and Attributes
11.7.4 Beijing Chong'ai International Animal Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.7.5 Beijing Chong'ai International Animal Hospital Recent Developments
11.8 MedVet
11.8.1 MedVet Corporation Information
11.8.2 MedVet Business Overview
11.8.3 MedVet Pet Euthanasia Product Features and Attributes
11.8.4 MedVet Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.8.5 MedVet Recent Developments
11.9 Zoetis
11.9.1 Zoetis Corporation Information
11.9.2 Zoetis Business Overview
11.9.3 Zoetis Pet Euthanasia Product Features and Attributes
11.9.4 Zoetis Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.9.5 Zoetis Recent Developments
11.10 AniCura
11.10.1 AniCura Corporation Information
11.10.2 AniCura Business Overview
11.10.3 AniCura Pet Euthanasia Product Features and Attributes
11.10.4 AniCura Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Meilian Zhonghe Animal Hospital
11.11.1 Meilian Zhonghe Animal Hospital Corporation Information
11.11.2 Meilian Zhonghe Animal Hospital Business Overview
11.11.3 Meilian Zhonghe Animal Hospital Pet Euthanasia Product Features and Attributes
11.11.4 Meilian Zhonghe Animal Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.11.5 Meilian Zhonghe Animal Hospital Recent Developments
11.12 Baker and Stone Animal Hospital
11.12.1 Baker and Stone Animal Hospital Corporation Information
11.12.2 Baker and Stone Animal Hospital Business Overview
11.12.3 Baker and Stone Animal Hospital Pet Euthanasia Product Features and Attributes
11.12.4 Baker and Stone Animal Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.12.5 Baker and Stone Animal Hospital Recent Developments
11.13 Abel Pet Hospital
11.13.1 Abel Pet Hospital Corporation Information
11.13.2 Abel Pet Hospital Business Overview
11.13.3 Abel Pet Hospital Pet Euthanasia Product Features and Attributes
11.13.4 Abel Pet Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.13.5 Abel Pet Hospital Recent Developments
11.14 PUPPY TOWN ANIMAL HOSPITAL
11.14.1 PUPPY TOWN ANIMAL HOSPITAL Corporation Information
11.14.2 PUPPY TOWN ANIMAL HOSPITAL Business Overview
11.14.3 PUPPY TOWN ANIMAL HOSPITAL Pet Euthanasia Product Features and Attributes
11.14.4 PUPPY TOWN ANIMAL HOSPITAL Pet Euthanasia Revenue and Gross Margin (2020-2025)
11.14.5 PUPPY TOWN ANIMAL HOSPITAL Recent Developments
12 Pet EuthanasiaIndustry Chain Analysis
12.1 Pet Euthanasia Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pet Euthanasia Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pet Euthanasia Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pet Euthanasia was estimated to be worth US$ 206 million in 2025 and is projected to reach US$ 334 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 116
USD 3950.00
(Single User License)
The global Pet Euthanasia market was valued at US$ 206 million in 2025 and is anticipated to reach US$ 334 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-04-19
Pages: 115
USD 2900.00
(Single User License)
The global Pet Euthanasia market size was US$ 193 million in 2024 and is forecast to a readjusted size of US$ 314 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 96
USD 4250.00
(Single User License)
The global market for Pet Euthanasia was estimated to be worth US$ 193 million in 2024 and is forecast to a readjusted size of US$ 314 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 105
USD 3950.00
(Single User License)
The global market for Pet Euthanasia was valued at US$ 193 million in the year 2024 and is projected to reach a revised size of US$ 314 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-02-07
Pages: 82
USD 2900.00
(Single User License)
The global market for Pet Euthanasia was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 106
USD 3950.00
(Single User License)
The global market for Pet Euthanasia was estimated to be worth US$ 206 million in 2025 and is projected to reach US$ 334 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 116
The global Pet Euthanasia market was valued at US$ 206 million in 2025 and is anticipated to reach US$ 334 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-04-19
Pages: 115
The global Pet Euthanasia market size was US$ 193 million in 2024 and is forecast to a readjusted size of US$ 314 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 96
The global market for Pet Euthanasia was estimated to be worth US$ 193 million in 2024 and is forecast to a readjusted size of US$ 314 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 105
The global market for Pet Euthanasia was valued at US$ 193 million in the year 2024 and is projected to reach a revised size of US$ 314 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-02-07
Pages: 82
The global market for Pet Euthanasia was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 106
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now